Pre-stroke Metformin Treatment is Neuroprotective Involving AMPK Reduction
Authors:
- 27 June 2016
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 41 (10) , 2719-2727
Abstract
Long-term metformin treatment reduces the risk of stroke. However, the effective administration pattern and indications of metformin on acute cerebral ischemia are unclear. To investigate the neuroprotective treatment duration and dosage of metformin on focal ischemia mice and the association of neuroprotection with 5′-adenosine monophosphate-activated protein kinase (AMPK) regulations, male C57BL/6 mice were subjected to permanent or transient middle cerebral artery occlusion (MCAO) and metformin of 3, 10 and 30 mg/kg was intraperitoneally injected 1, 3 or 7 days prior to MCAO, or at the onset, or 1, 3 or 6 h after reperfusion, respectively. Infarct volumes, neurological deficit score, cell apoptosis, both total and phosphorylated AMPK expressions were assessed. Results showed that prolonged pretreatment to 7 days of metformin (10 mg/kg) significantly ameliorated brain infarct, neurological scores and cell apoptosis in permanent MCAO mice. Shorter (3 days or 1 day) or without pretreatment of metformin was not effective, suggesting a pretreatment time window. In transient MCAO mice, metformin showed no neuroprotection even with pretreatment. The expressions of total and phosphorylated AMPK were sharply decreased with effective metformin pretreatments in ischemic brains. Our data provided the first evidence that in acute ischemic injury, a 7-days pretreatment duration of 10 mg/kg metformin is necessary for its neuroprotection, and metformin may not be beneficial in the cases of blood reperfusion.Keywords
Funding Information
- National Natural Science Foundation of China (81373393, 81273506, 81273490, 81402907)
- Natural Science Foundation of Zhejiang Province (LR15H310001, LY15H090004)
- Research Project of Department of Education of Zhejiang Province (Y201329908)
This publication has 32 references indexed in Scilit:
- Evaluating the Effects of Metformin Use on Height in Children and AdolescentsJAMA Pediatrics, 2015
- Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemiaMetabolic Brain Disease, 2014
- Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusionJournal of Neuroinflammation, 2014
- Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental strokeBrain, Behavior, and Immunity, 2014
- Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up StudyJournal of Stroke and Cerebrovascular Diseases, 2014
- Comparative analysis of the neurovascular injury and functional outcomes in experimental stroke models in diabetic Goto-Kakizaki ratsBrain Research, 2013
- Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearanceAutophagy, 2013
- AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling ActivityPLOS ONE, 2013
- Neuroprotective Effects of Adenosine Monophosphate- Activated Protein Kinase Inhibition and Gene Deletion in StrokeStroke, 2007
- Dose translation from animal to human studies revisitedThe FASEB Journal, 2007